These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 9413226)

  • 1. Differential expression of growth arrest, DNA damage genes and tumour suppressor gene p53 in naevi and malignant melanomas.
    Korabiowska M; Betke H; Kellner S; Stachura J; Schauer A
    Anticancer Res; 1997; 17(5A):3697-700. PubMed ID: 9413226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth arrest DNA damage gene expression in naevi.
    Korabiowska M; Brinck U; Betke H; Droese M; Berger H
    In Vivo; 1999; 13(3):247-50. PubMed ID: 10459501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of growth arrest DNA damage genes expression in oral melanomas.
    Korabiowska M; Betke H; Brinck U; Grohmann U; Hönig JF; Droese M
    In Vivo; 1999; 13(6):483-5. PubMed ID: 10757041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of AP-2alpha, c-kit, and cleaved caspase-6 and -3 in naevi and malignant melanomas of the skin. A possible role for caspases in melanoma progression?
    Woenckhaus C; Giebel J; Failing K; Fenic I; Dittberner T; Poetsch M
    J Pathol; 2003 Oct; 201(2):278-87. PubMed ID: 14517845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation between two independent DNA-repair pathways in different groups of naevi.
    Korabiowska M; Brinck U; Kellner S; Droese M; Berger H
    In Vivo; 1999; 13(3):243-5. PubMed ID: 10459500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of nm23 in melanoma progression and its prognostic significance.
    Betke H; Korabiowska M; Brinck U; Trybus-Gałuszka H; Kellner S; Okoń K; Stachura J; Droese M
    Pol J Pathol; 1998; 49(2):93-6. PubMed ID: 9798412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased GADD gene expression in human colon epithelial cells exposed to deoxycholate.
    Scott DW; Mutamba S; Hopkins RG; Loo G
    J Cell Physiol; 2005 Jan; 202(1):295-303. PubMed ID: 15316935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of GADD gene expression by phenethylisothiocyanate in human colon adenocarcinoma cells.
    Powolny A; Takahashi K; Hopkins RG; Loo G
    J Cell Biochem; 2003 Dec; 90(6):1128-39. PubMed ID: 14635187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mda-7 (IL-24) Mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK.
    Sarkar D; Su ZZ; Lebedeva IV; Sauane M; Gopalkrishnan RV; Valerie K; Dent P; Fisher PB
    Proc Natl Acad Sci U S A; 2002 Jul; 99(15):10054-9. PubMed ID: 12114539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of P-53 antigen in malignant melanomas and naevi of the head and neck area.
    Korabiowska M; Brinck U; Hoenig JF; Bartkowski SB; Kellner S; Marx D; Schauer A
    Anticancer Res; 1995; 15(3):885-9. PubMed ID: 7645976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcl2 and Bax expression in naevi and melanomas and their relation to ploidy status and proliferation.
    Korabiowska M; Brinck U; Ruschenburg I; Schlott T; Droese M; Stachura J
    Pol J Pathol; 1999; 50(1):17-21. PubMed ID: 10412270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P21 and Bax expression in cutaneous malignant melanomas: correlation with histologic prognostic parameters.
    Poyraz A; Akyürek N; Gönül II; Erdem O
    J Exp Clin Cancer Res; 2004 Dec; 23(4):625-31. PubMed ID: 15743033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The p53-dependent gamma-ray response of GADD45.
    Zhan Q; Bae I; Kastan MB; Fornace AJ
    Cancer Res; 1994 May; 54(10):2755-60. PubMed ID: 8168107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of cerbB3 in naevi and malignant melanomas.
    Korabiowska M; Mirecka J; Brinck U; Hoefer K; Marx D; Schauer A
    Anticancer Res; 1996; 16(1):471-4. PubMed ID: 8615656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent Ki-67 and p53 immunolabeling in cutaneous melanocytic neoplasms: an adjunct for recognition of the vertical growth phase in malignant melanomas?
    Kaleem Z; Lind AC; Humphrey PA; Sueper RH; Swanson PE; Ritter JH; Wick MR
    Mod Pathol; 2000 Mar; 13(3):217-22. PubMed ID: 10757331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteins involved in pRb and p53 pathways are differentially expressed in thin and thick superficial spreading melanomas.
    de Sá BC; Fugimori ML; Ribeiro Kde C; Duprat Neto JP; Neves RI; Landman G
    Melanoma Res; 2009 Jun; 19(3):135-41. PubMed ID: 19369901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of UV-irradiation on cell cycle, viability and the expression of p53, gadd153 and gadd45 genes in normal and HPV-immortalized human oral keratinocytes.
    Gujuluva CN; Baek JH; Shin KH; Cherrick HM; Park NH
    Oncogene; 1994 Jul; 9(7):1819-27. PubMed ID: 8208528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PUMA expression is significantly reduced in human cutaneous melanomas.
    Karst AM; Dai DL; Martinka M; Li G
    Oncogene; 2005 Feb; 24(6):1111-6. PubMed ID: 15690057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PA26, a novel target of the p53 tumor suppressor and member of the GADD family of DNA damage and growth arrest inducible genes.
    Velasco-Miguel S; Buckbinder L; Jean P; Gelbert L; Talbott R; Laidlaw J; Seizinger B; Kley N
    Oncogene; 1999 Jan; 18(1):127-37. PubMed ID: 9926927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.